About 1 100 reports

Cellular Tumor Antigen p## (Tumor Suppressor p## or Phosphoprotein p## or Antigen NY CO ## or TP##) - Dormant Products

  • Therapy
  • Oncology
  • Oncology
  • Pharmaceutical
  • World
  • Food Consumption
  • Drug Approval

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 Summary Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 provides in depth analysis on Cellular...

  • Monoclonal Antibody
  • World

Global Markets Direct's, 'Endoplasmin (## kDa Glucose Regulated Protein or Heat Shock Protein ## kDa Beta Member ## or Tumor Rejection Antigen ## or gp## Homolog or HSP##B##) H## 2020', provides in depth analysis on Endoplasmin (## kDa Glucose Regulated Protein or Heat Shock Protein ## kDa Beta Member ## or Tumor Rejection Antigen ## or gp## Homolog or HSP##B##) targeted pipeline therapeutics.

  • Oncology
  • Biopharmaceutical
  • World

Global Markets Direct's, 'Endoplasmin (## kDa Glucose Regulated Protein or Heat Shock Protein ## kDa Beta Member ## or Tumor Rejection Antigen ## or gp## Homolog or HSP##B##) H## 2019', provides in depth analysis on Endoplasmin (## kDa Glucose Regulated Protein or Heat Shock Protein ## kDa Beta Member ## or Tumor Rejection Antigen ## or gp## Homolog or HSP##B##) targeted pipeline therapeutics.

  • Pharmaceutical
  • Oncology
  • World
  • Direct Sales

Report Scope: The scope of this report is broad and covers category, source and applications of Tumor-specific Antigen.The market has been segmented by source into coding region and Non-Coding region. Revenue forecasts from 2017 to 2023 are given for each segment and regional market with estimated value derived...

  • Monoclonal Antibody
  • World

Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Summary Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells...

  • Vitamin
  • World

Report Includes: - An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer - Discussion of the development of TIL as a treatment option for melanoma and the possibilities to expand this therapy to other types of cancer - Exploration of adoptive T-cell therapy (ATCT) using antigen-specific...

  • Immunotherapy

"Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" Report Highlights: • KRAS Inhibitors Market Opportunity: > USD 1 Billion by 2025 • Initially US To Dominate KRAS Inhibitors Market: >90% Market Share • Number of KRAS Inhibitors In Trials: > 20 Drugs • Highest Phase of Clinical...

  • Therapy
  • Drug Development
  • Oncology
  • Clinical Trial
  • World

Report Scope: The key objectives of this study are to - - Review the historical development of CAR T-cell technology. - Discuss the principles of chimeric antigen receptor design. - Understand the mechanisms of action associated with CAR T-cell immunotherapy. - Highlight the ongoing clinical and non-clinical...

  • Immunotherapy
  • United States
  • World
  • Drug Approval

Vaccine to Target Cellular Tumor Antigen p## for Oncology – Drug Profile

  • Oncology
  • Pharmaceutical
  • World
  • Food Consumption
  • Drug Approval

Major players in the bi-specific MAbs or bispecific monoclonal antibodies market are Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Abbott, and AstraZeneca. The global bi-specific MAbS market is expected...

  • Monoclonal Antibody
  • United States
  • World
  • Biologics Sales

It causes cell lysis, which ruptures tumors, thereby releasing tumor-derived antigens.

  • Gene Therapy
  • Europe
  • Health Expenditure
  • Surgical Procedures Performed

The company has two core technology platforms: LentiVector and Tumour Antigen (##T##).

  • Gene Therapy
  • Healthcare
  • World
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Cancer Incidence

Report Scope: The current report offers a detailed picture of the point of care diagnostics market. This report highlights the current and future market potential for point of care diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities,...

  • Point Of Care Testing
  • World
  • Diabetes Prevalence

“Prostate Cancer Vaccines - Competitive Intelligence Analysis, 2019” report outlays comprehensive insights of present scenario and growth prospects across Prostate Cancer Vaccines. A detailed picture of the pipeline landscape is provided along with respective companies’ overview with summation of data from multiple sources and complete analysis...

  • Prostate Cancer
  • World
  • United States

Recently, immunologists found that allogeneic dendritic cells could deliver tumor antigens to bystander autologous dendritic cells, which then activated tumor antigen-specific immune responses against tumors.

  • Gene Therapy
  • World
  • Europe
  • North America
  • APAC
  • Cancer Incidence
  • Pharmaceutical R&D Expenditure

World Chronic Disease Prevalence Chronic Disease Wax Healthcare Pathology Tumor Antigen In Vitro Diagnostic Reagent Tissue Banking

  • Infectious Disease
  • World
  • Cancer Incidence
  • Chronic Disease Prevalence

Major players in the antibody-drug conjugates (ADCs) market are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., and Oxford BioTherapeutics. The global antibody drug conjugates market is expected to grow from $2.34 billion in 2020 to $2.6 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%....

  • Biopharmaceutical
  • World
  • Cancer Incidence

GDCT## GDC##, Respiratory Lung Cancer, Malignant Pleural Effusion Completed Phase II Interventional Gendicine First Affiliated Hospital of Liaoning Medical University ## Dec 2008 Cellular Tumor Antigen p## (Tumor Suppressor p## or Phosphoprotein p## or Antigen NY CO ## or TP##) Activator Cellular Tumor Antigen p## (Tumor Suppressor p## or Phosphoprotein p## or Antigen NY CO ## or TP##)

  • Clinical Trial
  • World
  • G7
  • APAC
  • Smoking Prevalence

Table ##: Tumor Antigen-Associated Biomarker Panel - Product Description

  • Diagnostics
  • Clinical Trial
  • United States
  • World
  • Europe
  • North America
  • California
  • Ireland
  • Bulgaria
  • Termination Of Pregnancy
  • Cervical Cancer Screening Coverage

Oncovir's clinical trials are used in the treatment of brain tumor antigens in patients with recurrent glioblastoma, diagnosed glioblastoma, malignant brain tumors and smallpox.

  • Infectious Disease
  • Drug Development
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Health Provider Density

Cellular Tumor Antigen p##

  • Eye Disease
  • Drug Development
  • World
  • Drug Approval
  • Cause-Specific Mortality Rate

Report Scope: Finding the right career path is one of the biggest challenges in every person’s life.We want to make sure we make the right choices and decisions concerning our future employment opportunities. And it’s no longer a one-time decision. Employment conditions and opportunities are not constantly evolving...

  • Immunotherapy
  • Monoclonal Antibody
  • Drug Development
  • Biotechnology
  • Cancer Immunotherapy
  • World

Its ITabs platform all together binds to CD## molecules on human T cells and to specific tumor antigens.

  • Drug Development
  • World
  • Jiangsu
  • South Africa
  • Mortality Rate
  • Pharmaceutical Registrations

Its ITabs platform all together binds to CD## molecules on human T cells and to specific tumor antigens.

  • Digestive System Disorder
  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Mortality Rate

Its ITabs platform all together binds to CD## molecules on human T cells and to specific tumor antigens.

  • Digestive System Disorder
  • Drug Development
  • World
  • Drug Approval
  • Hospital Discharge

Solid Tumors Antigen Phenotyping Identifies human leukocyte antigen for histocompatibility antigens using data from NGS

  • Clinical Trial
  • British Columbia
  • South Africa
  • Medical Devices Sales
  • Mobile Phone Production

The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers.

  • Cervical Cancer
  • United States
  • China
  • Cervical Cancer Screening Coverage
  • Drug Approval

Oncovir's clinical trials are used in the treatment of brain tumor antigens in patients with recurrent glioblastoma, diagnosed glioblastoma, malignant brain tumors and smallpox.

  • Infectious Disease
  • World
  • Drug Approval
  • Health Provider Density

Its ITabs platform all together binds to CD## molecules on human T cells and to specific tumor antigens.

  • Digestive System Disorder
  • World
  • Pharmaceutical Registrations
  • Cause-Specific Mortality Rate